AIROLDI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 13.957
EU - Europa 9.377
AS - Asia 4.231
SA - Sud America 337
AF - Africa 51
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 8
Totale 27.988
Nazione #
US - Stati Uniti d'America 13.640
IT - Italia 2.507
DE - Germania 1.886
SG - Singapore 1.176
CN - Cina 1.100
RU - Federazione Russa 997
HK - Hong Kong 818
SE - Svezia 812
IE - Irlanda 562
VN - Vietnam 502
PL - Polonia 500
UA - Ucraina 404
GB - Regno Unito 366
DK - Danimarca 359
FR - Francia 316
CA - Canada 287
BR - Brasile 275
FI - Finlandia 166
IN - India 159
AT - Austria 150
ID - Indonesia 104
NL - Olanda 91
TR - Turchia 87
KR - Corea 70
ES - Italia 50
JP - Giappone 49
BE - Belgio 44
PK - Pakistan 35
RO - Romania 34
CH - Svizzera 32
CZ - Repubblica Ceca 25
PT - Portogallo 21
TW - Taiwan 21
IR - Iran 20
AU - Australia 19
ZA - Sudafrica 19
AR - Argentina 18
MX - Messico 15
EG - Egitto 14
BD - Bangladesh 13
PH - Filippine 13
CL - Cile 11
GR - Grecia 11
PE - Perù 11
UZ - Uzbekistan 9
CO - Colombia 8
EU - Europa 8
IQ - Iraq 8
NZ - Nuova Zelanda 8
BY - Bielorussia 6
MA - Marocco 6
VE - Venezuela 6
AZ - Azerbaigian 5
CR - Costa Rica 5
EC - Ecuador 5
HU - Ungheria 5
JO - Giordania 5
LT - Lituania 5
DZ - Algeria 4
IL - Israele 4
LV - Lettonia 4
MY - Malesia 4
RS - Serbia 4
SA - Arabia Saudita 4
SV - El Salvador 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CY - Cipro 3
EE - Estonia 3
LU - Lussemburgo 3
AL - Albania 2
AM - Armenia 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
HR - Croazia 2
LB - Libano 2
NO - Norvegia 2
PA - Panama 2
PY - Paraguay 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MC - Monaco 1
ME - Montenegro 1
OM - Oman 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 27.986
Città #
Ann Arbor 4.738
Frankfurt am Main 1.195
Woodbridge 1.000
Milan 980
Wilmington 918
Fairfield 846
Hong Kong 808
Singapore 798
Chandler 763
Ashburn 571
Houston 562
Dublin 540
Kraków 476
Jacksonville 396
Seattle 373
Dearborn 289
Cambridge 280
Santa Clara 280
New York 255
Princeton 196
Beijing 184
Dong Ket 170
Nanjing 129
Vienna 121
Guangzhou 120
Shanghai 114
Toronto 91
Lawrence 87
Jakarta 82
Hanoi 81
Altamura 78
Moscow 78
Ho Chi Minh City 67
Helsinki 66
Boardman 64
Montréal 64
Rome 64
Lachine 63
Hefei 62
Los Angeles 61
Hangzhou 60
Kent 56
Munich 54
San Diego 52
Seoul 52
Council Bluffs 47
Nanchang 43
Brussels 42
Ottawa 40
Fremont 38
Andover 36
Grafing 36
Nuremberg 36
Tianjin 36
Desio 33
Shenyang 31
London 30
Brescia 29
Hebei 28
Changsha 27
Florence 26
Cinisello Balsamo 24
Jinan 24
São Paulo 24
Hyderabad 23
Chicago 22
Pune 22
Turku 22
Falls Church 21
Jiaxing 21
Dallas 20
Monza 20
Redmond 20
Padova 19
Genoa 18
Norwalk 18
Auburn Hills 17
Pioltello 17
Zhengzhou 17
Düsseldorf 16
Brooklyn 15
Caivano 15
Sacramento 15
Bienno 14
Como 14
Kunming 14
Paris 14
Parma 14
Verona 14
Washington 14
Boston 13
Edmonton 13
Huizen 13
Kiev 13
Naples 13
Taipei 13
Torino 13
Turin 13
Ankara 12
Faisalabad 12
Totale 19.598
Nome #
Structure–Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists 652
Coffee variety, origin and extraction procedure: Implications for coffee beneficial effects on human health 630
Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-RasG13D 604
Glucose-derived Ras pathway inhibitors: evidence of Ras-ligand binding and Ras-GEF (Cdc25) interaction inhibition 536
Green coffee extract enhances oxidative stress resistance and delays aging in Caenorhabditis elegans 532
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 515
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 504
The Multi-Level Mechanism of Action of a Pan-Ras Inhibitor Explains its Antiproliferative Activity on Cetuximab-Resistant Cancer Cells 499
Natural compounds in cancer prevention: effects of coffee extracts and their main polyphenolic component 5-CQA on oncogenic Ras proteins 481
Methacycline displays a strong efficacy in reducing toxicity in a SCA3 Caenorhabditis elegans model 464
Sugar-derived Ras inhibitors: group epitope mapping by NMR spectroscopy and biological evaluation 452
Design, Synthesis and Biological Evaluation of Levoglucosenone-derived Ras Activation Inhibitors 444
Design, synthesis and biological evaluation of sugar-derived Ras inhibitors 441
Re LPS biogenetic pathway: Enzyme characterisation and synthetic efforts towards inhibitors 428
Glycoconjugates in cancer therapy 418
Studies on the mechanism of action of a new class of inhibitors of Ras activation 412
Glycan carriers as glycotools for medicinal chemistry applications 395
NMR-driven identification of anti-amyloidogenic compounds in green and roasted coffee extracts 393
Nuclear Magnetic Resonance as an Attractive Resource for Monitoring Surveillance Candidates of Acute and Chronic Lung Disorders 370
Epigallocatechin-3-gallate and related phenol compounds redirect the amyloidogenic aggregation pathway of ataxin-3 towards non-toxic aggregates and prevent toxicity in neural cells and Caenorhabditis elegans animal model 359
Protein Kinase A Activation Promotes Cancer Cell Resistance to Glucose Starvation and Anoikis 337
bioNMR-based identification of natural anti-Aβ compounds in Peucedanum ostruthium 337
Flavonoids in the treatment of alzheimer’s and other neurodegenerative diseases 334
Targeting GRP receptor: design, synthesis and preliminary biological characterization of new non-peptide antagonists of bombesin 332
Synthesis, Molecular Modeling and Biological Evaluation of Metabolically Stable Analogues of the Endogenous Fatty Acid Amide Palmitoylethanolamide 310
Flavonoids and their glycosides as anti-amyloidogenic compounds: Aβ1-42 interaction studies to gain new insights on their potential for Alzheimer's disease prevention and therapy 297
Effectiveness of Vigna unguiculata seed extracts in preventing colorectal cancer 293
Methionine supplementation stimulates mitochondrial respiration 284
From cancer metabolism to new biomarkers and drug targets 283
On-cell Saturation Transfer Difference NMR study of Bombesin binding to GRP receptor 277
NMR-based Lavado cocoa chemical characterization and comparison with fermented cocoa varieties: insights on cocoa’s anti-amyloidogenic activity 275
Versatile and Efficient Targeting Using a Single Nanoparticulate Platform and its Application to Cancer and Alzheimer's Disease 272
Arabinose 5-phosphate isomerase as a target for antibacterial design: studies with substrate analogues and inhibitors 267
Enhanced amino acid utilization sustains growth of cells lacking Snf1/AMPK 266
Green and Roasted Coffee Extracts Inhibit Interferon-β Release in LPS-Stimulated Human Macrophages 264
Phosphonate Analogues of Arabinose 5-Phosphate: Putative Ligands for Arabinose 5-Phosphate Isomerases 259
1H NMR to Evaluate the Metabolome of Bronchoalveolar Lavage Fluid (BALf) in Bronchiolitis Obliterans Syndrome (BOS): Toward the Development of a New Approach for Biomarker Identification 259
New targets for antibacterial design: Kdo biosynthesis and LPS machinery transport to the cell surface 256
Nanoliposomes presenting on surface a cis-glycofused benzopyran compound display binding affinity and aggregation inhibition ability towards Amyloid b1-42 peptide 253
Curcumin derivatives as new ligands of Aβ peptides 252
NMR analysis of budding yeast metabolomics: A rapid method for sample preparation 252
Targeting bacterial biofilm: a new LecA multivalent ligand with inhibitory activity 252
Structural modifications of cis-glycofused benzopyran compounds and their influence on the binding to amyloid-β peptide 250
Natural glycoconjugates with antitumor activity 247
Cis-Glyco-Fused Benzopyran Derivatives as Hit Compounds for the Development of Therapeutic and Diagnostic Tools against Neurodegenerative Diseases 247
The Kdo biosynthetic pathway toward OM biogenesis as target in antibacterial drug design and developmen 246
How Epigallocatechin-3-gallate and Tetracycline Interact with the Josephin Domain of Ataxin-3 and Alter Its Aggregation Mode 246
Carbohydrate Mimetics and Scaffolds: Sweet Spots in Medicinal Chemistry 245
Metabolomic profiling of beers: Combining 1H NMR spectroscopy and chemometric approaches to discriminate craft and industrial products 245
Synthesis and biological evaluation of arabinose 5-phosphate mimics modified at position five 245
Synthesis and biological evaluation of a small library of nojirimycin derived bicyclic iminosugars 241
Towards a universal approach based on omics technologies for the quality control of food 237
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 235
Targeting Bacterial Membranes: NMR Characterization of Substrate Recognition and Binding Requirements of D-arabinose 5P Isomerase, a key enzyme in the biosynthesis of LPS 234
1H NMR to Explore the Metabolome of Exhaled Breath Condensate in α1-Antitrypsin Deficient Patients: A Pilot Study 231
Carbohyrate scaffolds in chemical genetic studies 230
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 224
Fructose-Based Proline Analogues: Exploring the Prolyl trans/cis-Amide Rotamer Population in Model Peptides 220
Solid-phase supported mimic of GDP-l-galactose 215
NMR Molecular Recognition Studies for the Elucidation of Protein and Nucleic Acid Structure and Function 215
Curcumin derivatives: Aβ-ligands as potential diagnostic and therapeutic tools for alzheimer's disease 214
Exploiting the Therapeutic Potential of 8-β-d-Glucopyranosylgenistein: Synthesis, Antidiabetic Activity, and Molecular Interaction with Islet Amyloid Polypeptide and Amyloid β-Peptide (1-42) 213
Antimicrobial peptides: Insights into membrane permeabilization, lipopolysaccharide fragmentation and application in plant disease control 211
Pyrrolo[2,1-c][1,4]benzodiazepine as a scaffold for the design and synthesis of anti-tumour drugs 210
The Molecular Assembly of Amyloid Aβ Controls Its Neurotoxicity and Binding to Cellular Proteins 210
Fluorinated Arabinose-5-Phosphate Analogues as Potential Antibactericals 210
Targeting Bacterial Membranes: Identification of Pseudomonas aeruginosaD-Arabinose-5P Isomerase and NMR Characterisation of its Substrate Recognition and Binding Properties 202
Tetracycline prevents Aβ oligomer toxicity through an atipical supramolecular interaction 200
On-cell Saturation Transfer Difference NMR for the identification of FimH ligands and inhibitors 189
NMR-driven identification of cinnamon bud and bark components with anti-Aβ activity 189
Cell-Free and In Vivo Characterization of the Inhibitory Activity of Lavado Cocoa Flavanols on the Amyloid Protein Ataxin-3: Toward New Approaches against Spinocerebellar Ataxia Type 3 187
Development of new potential antitumor drugs based on Ras protein inhibition 187
Fluorescent amyloid β-peptide ligand derivatives as potential diagnostic tools for Alzheimer’s disease 184
Natural Compounds against Neurodegenerative Diseases: Molecular Characterization of the Interaction of Catechins from Green Tea with Aβ1-42, PrP106-126, and Ataxin-3 Oligomers 183
On-cell NMR screening of multivalent ligands for bacterial targeting 181
Sugar-Based Enantiomeric and Conformationally Constrained Pyrrolo[2,1-c][1,4]-Benzodiazepines as Potential GABAALigands 179
Cis-glyco-fused benzopyran compounds as new amyloid β peptide ligands 178
NMR Protein-Ligand Interaction Studies under Non-Homogeneous Conditions for Biomaterial Generation: A Model For Artificial Lectin-Carbohydrate Recognition 178
Multivalent calix[4]arene-based mannosylated dendrons as new FimH ligands and inhibitors 177
Cheese-whey permeate improves the fitness of Escherichia coli cells during recombinant protein production 176
Global Scientific Challenges: Perspectives from Young Scientists 176
Synthesis of 3-Deoxy-D-threopentofuranose 5-Phosphate, a Substrate of Arabinose 5-Phosphate Isomerase 175
Performance Assessment in Fingerprinting and Multi Component Quantitative NMR Analyses 171
Alzheimer's Disease Prevention through Natural Compounds: Cell-Free, in Vitro, and in Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity 170
New C-glycosylpolyphenol antidiabetic agents, effect on glucose tolerance and interaction with beta-amyloid. Therapeutic applications of the synthesized agent(s) and of Genista tenera ethyl acetate extracts containing some of those agents 167
New tricyclic compounds, process for their manufacture and their use as ligands of beta-alyloid peptides 166
HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders 166
A Contribution to the Harmonization of Non-targeted NMR Methods for Data-Driven Food Authenticity Assessment 161
Aβ Monomers, Oligomers and Fibrils: Structural Features 159
Natural Compounds against Alzheimer´s Disease: Molecular Recognition of Aβ1–42 Peptide by Salvia sclareoides Extract and its Major Component, Rosmarinic Acid, as Investigated by NMR 159
Synthesis of C- and S-Glycosides 159
Nutraceutical approach to increase healthy aging using Caenorhabditis elegans as a model organism 157
Aminated Sugars, Synthesis, and Biological Activity 156
Synthesis of C- and S-Glycosides 154
Phytotoxicity, nematicidal activity and chemical constituents of Peucedanum ostruthium (L.) W.D.J.Koch (Apiaceae) 152
Nuovi composti triciclici glicofusi, procedimento per la loro produzione e loro impiego quali ligandi dei peptidi β amiloidi (Aβ) 148
Saturation Transfer Difference NMR Experiments of Membrane Proteins in Living Cells under HR-MAS Conditions: the Interaction of the SGLT1 Co-transporter with Its Ligands 147
Anticancer Effects of Wild Mountain Mentha longifolia Extract in Adrenocortical Tumor Cell Models 147
null 146
A community-built calibration system: The case study of quantification of metabolites in grape juice by qNMR spectroscopy 136
Totale 27.023
Categoria #
all - tutte 86.931
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.931


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.409 239 182 370 416 318 376 362 404 375 494 294 579
2021/20223.283 308 342 310 309 161 271 222 154 283 246 273 404
2022/20233.885 498 944 488 370 326 514 127 195 199 57 99 68
2023/20242.424 104 119 158 188 269 483 376 131 181 68 99 248
2024/20255.977 282 582 519 308 425 274 279 230 594 881 543 1.060
2025/202617 17 0 0 0 0 0 0 0 0 0 0 0
Totale 29.030